Recent Advances on Polyoxometalates as Metallodrug Agents for Alzheimer's Disease

被引：4
|
作者：
Ma, Mengmeng [1 ,2 ]
Qu, Xiaogang [1 ]
机构：
[1] Chinese Acad Sci, Changchun Inst Appl Chem, Lab Chem Biol, State Key Lab Rare Earth Resource Utilizat, Changchun 130022, Peoples R China
[2] Univ Sci & Technol China, Coll Appl Chem & Engn, Hefei 230026, Peoples R China
来源：
CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE | 2020年 / 41卷 / 05期
基金：
中国国家自然科学基金;
关键词：
Alzheimer's disease; Polyoxometalates; beta-Amyloid; AMYLOID-BETA-PEPTIDE; AGGREGATION; NANOPARTICLES; INHIBITORS; CHEMISTRY; DESIGN;
D O I：
10.7503/cjcu20190714
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
Alzheimer's disease(AD) is a progressive neurodegenerative disorder characterized by cognitive dysfunction and memory loss. Although the exact pathogenesis of AD remains unclear, recent evidences have demonstrated that the accumulation and deposition of beta-amyloid peptide(A beta) is a key step in AD pathogenesis. Polyoxometalates(POMs) have the merits of adjustable structures, ease of preparation, and low cost, and thus have shown promising in AD treatment. Hence, recent advances on the POMs as a novel AD metallodrug agent are summarized.
引用
收藏
页码：884 / 891
页数：8
相关论文
共 42 条
  • [1] Platinum-based inhibitors of amyloid-β as therapeutic agents for Alzheimer's disease
    Barnham, Kevin J.
    Kenche, Vijaya B.
    Ciccotosto, Giuseppe D.
    Smith, David P.
    Tew, Deborah J.
    Liu, Xiang
    Perez, Keyla
    Cranston, Greg A.
    Johanssen, Timothy J.
    Volitakis, Irene
    Bush, Ashley I.
    Masters, Colin L.
    White, Anthony R.
    Smith, Jeffrey P.
    Cherny, Robert A.
    Cappai, Roberto
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (19) : 6813 - 6818
  • [2] Polyoxometalates as Potential Next-Generation Metallodrugs in the Combat Against Cancer
    Bijelic, Aleksandar
    Aureliano, Manuel
    Rompel, Annette
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2019, 58 (10) : 2980 - 2999
  • [3] The antibacterial activity of polyoxometalates: structures, antibiotic effects and future perspectives
    Bijelic, Aleksandar
    Aureliano, Manuel
    Rompel, Annette
    [J]. CHEMICAL COMMUNICATIONS, 2018, 54 (10) : 1153 - 1169
  • [4] Mo polyoxometalate nanoclusters capable of inhibiting the aggregation of Aβ-peptide associated with Alzheimer's disease
    Chen, Qingchang
    Yang, Licong
    Zheng, Chuping
    Zheng, Wenjing
    Zhang, Jingnan
    Zhou, Yunshan
    Liu, Jie
    [J]. NANOSCALE, 2014, 6 (12) : 6886 - 6897
  • [5] Chirality-Selected Chemical Modulation of Amyloid Aggregation
    Gao, Nan
    Du, Zhi
    Guan, Yijia
    Dong, Kai
    Ren, Jinsong
    Qu, Xiaogang
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2019, 141 (17) : 6915 - 6921
  • [6] Polyoxometalate-based nanozyme: Design of a multifunctional enzyme for multi-faceted treatment of Alzheimer's disease
    Gao, Nan
    Dong, Kai
    Zhao, Andong
    Sun, Hanjun
    Wang, Ying
    Ren, Jinsong
    Qu, Xiaogang
    [J]. NANO RESEARCH, 2016, 9 (04) : 1079 - 1090
  • [7] Gold-Nanoparticle-Based Multifunctional Amyloid-β Inhibitor against Alzheimer's Disease
    Gao, Nan
    Sun, Hanjun
    Dong, Kai
    Ren, Jinsong
    Qu, Xiaogang
    [J]. CHEMISTRY-A EUROPEAN JOURNAL, 2015, 21 (02) : 829 - 835
  • [8] Transition-metal-substituted polyoxometalate derivatives as functional anti-amyloid agents for Alzheimer's disease
    Gao, Nan
    Sun, Hanjun
    Dong, Kai
    Ren, Jinsong
    Duan, Taicheng
    Xu, Can
    Qu, Xiaogang
    [J]. NATURE COMMUNICATIONS, 2014, 5
  • [9] Polyoxometalates as Inhibitors of the Aggregation of Amyloid β Peptides Associated with Alzheimer's Disease
    Geng, Jie
    Li, Meng
    Ren, Jinsong
    Wang, Enbo
    Qu, Xiaogang
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2011, 50 (18) : 4184 - 4188
  • [10] Major advances in the hydrolysis of peptides and proteins by metal ions and complexes
    Grant, Kathryn B.
    Kassai, Miki
    [J]. CURRENT ORGANIC CHEMISTRY, 2006, 10 (09) : 1035 - 1049
12345